A 24-year-old man with a history of depression is brought to the emergency room because of a drug overdose. He is experiencing some nausea and vomiting, but no other symptoms. Physical examination and vital signs are normal. Six hours prior to presentation, he intentionally took 40 tablets of acetaminophen (500 mg/tablet). Which of the following is the most appropriate next step in management?
Which of the following drugs can cause cholestatic jaundice?
The rationale for using ethanol in methanol poisoning is that it:
Diffusion of oxygen at the tissue level is affected in all the following poisoning except?
Hyperthermia is caused by:
Chronic hepatitis of moderate to severe nature can be a result of treatment with which of the following drugs?
Which of the following is NOT a management option for acute severe digitalis toxicity?
Bremelanotide is used for which of the following conditions?
All of the following are causes of drug-induced lupus erythematosus, except?
Serotonin syndrome may be precipitated by all of the following medications, except?
Explanation: <h3>Explanation</h3><p><b>1. Why Option D is Correct:</b><br/>Acetaminophen (Paracetamol) is normally metabolized via glucuronidation and sulfation. In an overdose, these pathways saturate, and the drug is diverted to the <b>CYP450 system</b> (specifically CYP2E1), producing the highly reactive toxic metabolite <b>NAPQI</b> (<i>N-acetyl-p-benzoquinone imine</i>).</p><p>Under normal conditions, NAPQI is neutralized by <b>Glutathione</b>. In overdose, glutathione stores are depleted, leading to hepatic necrosis. <b>N-acetylcysteine (NAC)</b> is the specific antidote because it acts as a glutathione precursor and substitute, directly binding to and detoxifying NAPQI [1]. Since the patient presented 6 hours after ingestion (within the critical 8-hour window for maximum efficacy), NAC administration is the priority. Best results with acetylcysteine are observed when given within 8–10 hours of overdose [2].</p><p><b>2. Why Other Options are Incorrect:</b></p><ul><li><b>Option A (Ethanol):</b> Ethanol is used in <b>Methanol or Ethylene glycol</b> poisoning to compete for the enzyme alcohol dehydrogenase. In acetaminophen toxicity, chronic ethanol use actually <i>increases</i> toxicity by inducing CYP2E1.</li><li><b>Option B (Naloxone):</b> This is a competitive opioid antagonist used for <b>Opioid overdose</b> (characterized by respiratory depression and miosis), not acetaminophen.</li><li><b>Option C (Prostacyclins):</b> While some studies suggest they may help in late-stage fulminant hepatic failure, they are not the standard of care or the "next step" in acute poisoning.</li></ul><p><b>3. NEET-PG High-Yield Pearls:</b></p><ul><li><b>Toxic Dose:</b> >150 mg/kg in children or >7.5–10g in adults.</li><li><b>Rumack-Matthew Nomogram:</b> Used to determine the need for NAC based on plasma acetaminophen levels (only valid between 4 and 24 hours post-ingestion). The severity of poisoning is estimated from a serum acetaminophen concentration measurement [1].</li><li><b>Clinical Stages:</b> Stage 1 (0-24h) is often asymptomatic or involves minor GI upset [1]; Stage 3 (72-96h) is the peak of hepatotoxicity (elevated ALT/AST, jaundice). Massive hepatic necrosis and encephalopathy can occur 48–72 hours or longer after ingestion [3].</li><li><b>NAC Protocol:</b> Can be given IV (21-hour protocol) or Orally (72-hour protocol).</li></ul>
Explanation: ### Explanation Drug-induced liver injury (DILI) is a high-yield topic for NEET-PG, often categorized into **Hepatocellular** (necrosis) and **Cholestatic** (impaired bile flow) patterns. **1. Why Option B is Correct:** The drugs in this option are classic causes of **cholestatic jaundice**: * **Estrogens:** Cause dose-dependent cholestasis by inhibiting the bile salt export pump (BSEP) and increasing canalicular membrane permeability. This is clinically seen as "intrahepatic cholestasis of pregnancy" or OCP-induced jaundice. * **Cyclosporine:** This immunosuppressant inhibits the ATP-dependent transport of bile acids, leading to conjugated hyperbilirubinemia. * **Phenothiazines (e.g., Chlorpromazine):** These cause a hypersensitivity-type (idiosyncratic) cholestatic reaction, often characterized by "bland cholestasis" with minimal inflammation. **2. Analysis of Incorrect Options:** * **INH (Isoniazid):** A hallmark cause of **hepatocellular necrosis** (elevated ALT/AST), not primarily cholestasis. It produces a toxic metabolite (acetylhydrazine) that causes liver cell death. * **Ethambutol:** Primarily known for **optic neuritis**. While it can rarely cause hepatotoxicity, it is not a classic or common cause of cholestatic jaundice compared to the drugs in Option B. * **Options A, C, and D** are incorrect because they include either INH or Ethambutol, which do not fit the primary cholestatic profile. **3. NEET-PG High-Yield Pearls:** * **Hepatocellular Pattern:** INH, Rifampicin, Pyrazinamide, Paracetamol, Halothane. * **Cholestatic Pattern:** Estrogens, Anabolic steroids, Chlorpromazine, Erythromycin estolate, Cyclosporine. * **Mixed Pattern:** Phenytoin, Carbamazepine. * **Key Distinction:** In cholestatic jaundice, **Alkaline Phosphatase (ALP)** is significantly more elevated than ALT/AST, and patients often present with **pruritus**.
Explanation: The toxicity of methanol is not caused by the alcohol itself, but by its metabolic products. Methanol is metabolized by the enzyme **Alcohol Dehydrogenase (ADH)** into **Formaldehyde**, which is then rapidly converted by aldehyde dehydrogenase into **Formic Acid**. Formic acid is the primary toxin responsible for metabolic acidosis and retinal damage (blindness). **1. Why Option C is Correct:** Ethanol acts as a **competitive inhibitor** of Alcohol Dehydrogenase. Ethanol has a much higher affinity (approx. 10–20 times) for ADH than methanol. By saturating the enzyme, ethanol prevents the conversion of methanol into its toxic metabolites [1]. This allows the parent methanol to be excreted unchanged by the kidneys or lungs, preventing the "lethal synthesis" of formic acid. **2. Why Other Options are Incorrect:** * **Option A:** Ethanol does not block methanol receptors; it acts enzymatically. * **Option B:** Ethanol **inhibits**, rather than stimulates, the metabolism of methanol. Stimulating metabolism would actually increase toxicity by producing more formic acid. * **Option D:** While **Folic acid (Leucovorin)** is administered in methanol poisoning to enhance the breakdown of formic acid into $CO_2$ and $H_2O$, ethanol itself does not replenish folate stores. **NEET-PG High-Yield Pearls:** * **Antidote of Choice:** **Fomepizole** is now the preferred specific antidote because it is a potent ADH inhibitor without the CNS depressant effects of ethanol [1]. * **Classic Presentation:** "Snowstorm vision" or blurred vision, high anion gap metabolic acidosis (HAGMA), and an increased osmolar gap. * **Treatment Triad:** 1. Fomepizole/Ethanol (Inhibit ADH), 2. Sodium Bicarbonate (Treat acidosis), 3. Hemodialysis (Remove methanol/formate).
Explanation: This question tests the understanding of the **Oxygen Cascade** and the specific mechanisms by which toxins interfere with oxygen delivery and utilization. ### **Explanation** The correct answer is **Curare (B)**. Curare is a non-depolarizing neuromuscular blocking agent that acts at the nicotinic receptors of the motor endplate [2]. It causes **respiratory failure** by paralyzing the diaphragm and intercostal muscles. However, it does **not** interfere with the biochemical or physical diffusion of oxygen at the tissue level; if the patient is mechanically ventilated, oxygen diffusion remains perfectly normal. ### **Why the other options are incorrect:** * **Carbon Monoxide (A):** CO binds to hemoglobin with 200x higher affinity than $O_2$, forming Carboxyhemoglobin. It causes a **leftward shift** of the oxygen-dissociation curve, preventing the release (diffusion) of $O_2$ from hemoglobin to the tissues [1]. * **Phosgene (C):** This is a pulmonary irritant that causes severe **alveolar-capillary membrane damage** and non-cardiogenic pulmonary edema. This physical barrier and the destruction of the membrane directly impair the diffusion of gases. * **Cyanides (D):** Cyanide inhibits **Cytochrome Oxidase $a_3$** in the electron transport chain. This prevents the tissues from utilizing oxygen (histotoxic hypoxia). While $O_2$ is present in the blood, the concentration gradient for diffusion is abolished because the cellular "sink" for oxygen is blocked. ### **NEET-PG High-Yield Pearls** * **Cyanide Poisoning:** Characterized by a narrow arterial-venous $O_2$ difference (venous blood remains bright red). Antidote: Nitrites + Sodium Thiosulfate or Hydroxocobalamin. * **CO Poisoning:** "Cherry red" skin discoloration (post-mortem). Treatment: 100% Hyperbaric Oxygen. * **Curare Antidote:** Neostigmine (acetylcholinesterase inhibitor) combined with Glycopyrrolate.
Explanation: **Explanation:** The correct answer is **MAO inhibitors**. Hyperthermia is a classic component of **Serotonin Syndrome**, which occurs due to an excess of synaptic serotonin [1]. MAO inhibitors (MAOIs) prevent the breakdown of serotonin; when combined with other serotonergic drugs (like SSRIs or Meperidine), they can trigger a life-threatening hypertensive crisis and hyperpyrexia [2], [3]. Additionally, MAOIs can cause hyperthermia through excessive metabolic activity and muscle rigidity. **Analysis of Options:** * **Anticholinergics (Option A):** While these cause "Atropine fever" by inhibiting sweating (anhidrosis), they typically lead to **hyperpyrexia** rather than true central hyperthermia. However, in the context of competitive exams, MAOIs are a more potent cause of systemic hyperthermic syndromes. * **Lithium (Option B):** Lithium toxicity primarily presents with neurological symptoms (tremors, ataxia, seizures) and renal issues (NDI). It does not typically cause hyperthermia unless associated with Serotonin Syndrome or NMS when used with antipsychotics. * **Chlorpromazine (Option D):** As a typical antipsychotic, it is more commonly associated with **hypothermia** (due to inhibition of the hypothalamus) or **Neuroleptic Malignant Syndrome (NMS)**. However, NMS is an idiosyncratic reaction rather than a direct pharmacological effect of the drug itself. **NEET-PG High-Yield Pearls:** 1. **Drug-Induced Hyperthermia Triad:** Always differentiate between **Serotonin Syndrome** (MAOIs/SSRIs - presents with hyperreflexia/clonus), **NMS** (Antipsychotics - presents with "lead-pipe" rigidity), and **Malignant Hyperthermia** (Halothane/Succinylcholine - treated with Dantrolene). 2. **Cheese Reaction:** MAOIs + Tyramine-rich food lead to hypertensive crisis, not just hyperthermia [2]. 3. **Antidote for Serotonin Syndrome:** Cyproheptadine (5-HT2A antagonist).
Explanation: **Explanation:** **Correct Answer: A. Isoniazid (INH)** Isoniazid is a cornerstone of anti-tubercular therapy (ATT) but is notorious for its hepatotoxicity. The drug is metabolized in the liver via **acetylation** (by NAT2 enzyme) to acetyl-isoniazid and subsequently to **acetylhydrazine**. Acetylhydrazine is a potent hepatotoxin that causes oxidative stress and hepatocellular necrosis. While many patients experience a transient, asymptomatic rise in transaminases, a small percentage develop **chronic hepatitis** that can mimic autoimmune hepatitis or progress to cirrhosis if the drug is not discontinued. Risk is higher in "slow acetylators," the elderly, and those with pre-existing liver disease. **Analysis of Incorrect Options:** * **B. Sulfonamides:** These typically cause hypersensitivity reactions. In the liver, they are more commonly associated with **granulomatous hepatitis** or acute focal necrosis rather than chronic hepatitis. * **C. Estrogens:** These are classically associated with **cholestatic jaundice** (impaired bile flow) and an increased risk of hepatic adenomas, rather than chronic inflammatory hepatitis. * **D. Erythromycin:** Specifically the **estolate salt** of erythromycin is a well-known cause of **acute cholestatic hepatitis**, presenting with upper abdominal pain and jaundice, usually resolving upon withdrawal. **NEET-PG High-Yield Pearls:** * **INH Toxicity:** The risk of hepatotoxicity increases significantly when INH is combined with **Rifampicin** (due to enzyme induction). * **Management:** If AST/ALT levels exceed **3 times** the upper limit of normal (with symptoms) or **5 times** (without symptoms), ATT should be stopped. * **Other drugs causing Chronic Hepatitis:** Methyldopa, Nitrofurantoin, and Amiodarone.
Explanation: In digitalis toxicity, the management strategy depends heavily on the patient's serum potassium levels. **Why Potassium Supplementation is the Correct Answer:** While potassium is used to treat digitalis-induced arrhythmias in **mild-to-moderate** toxicity (because potassium competes with digoxin for the Na+/K+ ATPase pump), it is **contraindicated in acute severe toxicity**. Severe toxicity causes massive inhibition of the Na+/K+ ATPase pump throughout the body, preventing potassium from entering cells and leading to **hyperkalemia**. Administering more potassium in a patient who is already hyperkalemic can lead to fatal cardiac arrest. **Explanation of Other Options:** * **Digibind (Digoxin-specific Fab fragments):** This is the **first-line and definitive treatment** for severe digitalis toxicity. It rapidly binds to free digoxin, neutralizing its effect and promoting excretion. * **Lignocaine:** This is the **drug of choice for digitalis-induced ventricular arrhythmias**. It is preferred because it does not further depress AV conduction, unlike other anti-arrhythmics. **High-Yield Clinical Pearls for NEET-PG:** * **Most common arrhythmia:** Ventricular Bigeminy. * **Most characteristic arrhythmia:** Paroxysmal Atrial Tachycardia (PAT) with AV block. * **ECG changes:** "Reverse Tick" or "Sagging" ST-segment depression (Coved ST). * **Electrolyte triggers:** Hypokalemia, Hypomagnesemia, and Hypercalcemia predispose a patient to toxicity. * **Indication for Digibind:** Serum potassium > 5.0 mEq/L, life-threatening arrhythmias, or ingestion of >10 mg in adults.
Explanation: Bremelanotide is a novel pharmacotherapeutic agent approved by the FDA for the treatment of generalized Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. 1. Mechanism of Action: Bremelanotide is a non-selective Melanocortin Receptor Agonist. It primarily targets the Melanocortin 4 receptor (MC4R) in the central nervous system. Unlike hormonal therapies, it modulates brain pathways involved in sexual response by increasing excitatory signals and potentially reducing inhibitory signals associated with sexual desire. It is administered as a subcutaneous injection at least 45 minutes before anticipated sexual activity. 2. Analysis of Incorrect Options: Erectile Dysfunction (B): While melanocortin agonists were initially studied for ED, the primary treatments remain PDE-5 inhibitors (Sildenafil, Tadalafil) or Alprostadil. Bremelanotide is specifically indicated for HSDD in women. Benign Prostatic Hyperplasia (C): BPH is managed using alpha-1 blockers (Tamsulosin) or 5-alpha reductase inhibitors (Finasteride). Renal Cell Carcinoma (D): RCC is treated with surgical resection, tyrosine kinase inhibitors (Sunitinib), or immunotherapy (Nivolumab). High-Yield Clinical Pearls for NEET-PG: Flibanserin is the other major drug for HSDD; however, it is a 5-HT1A agonist/5-HT2A antagonist and is taken daily (unlike the "on-demand" use of Bremelanotide). Side Effects: The most common side effect of Bremelanotide is nausea. It can also cause a transient increase in blood pressure and focal hyperpigmentation. Contraindication: It should be avoided in patients with uncontrolled hypertension or known cardiovascular disease.
Explanation: **Explanation:** Drug-Induced Lupus Erythematosus (DILE) is an autoimmune phenomenon where certain drugs trigger symptoms mimicking Systemic Lupus Erythematosus (SLE). The hallmark of DILE is the presence of **Anti-Histone Antibodies** (positive in >90% of cases), while anti-dsDNA antibodies are typically absent. **Why Clofibrate is the Correct Answer:** Clofibrate is a fibric acid derivative used to lower lipid levels. It is associated with side effects like myositis and gallstones but is **not** known to cause drug-induced lupus. Therefore, it is the "except" in this list. **Analysis of Other Options:** * **Hydralazine (Option A):** This is the most common cause of DILE. It is metabolized by N-acetylation; "slow acetylators" are at a significantly higher risk of developing lupus-like symptoms. * **Penicillamine (Option C):** Used in Wilson’s disease and rheumatoid arthritis, it is a well-documented trigger for DILE and other autoimmune conditions like pemphigus. * **Isoniazid (Option D):** A primary anti-tubercular drug that, like hydralazine, undergoes acetylation. It is a frequent cause of DILE, especially in slow acetylators. **NEET-PG High-Yield Pearls:** * **Mnemonic (HIPPS):** **H**ydralazine, **I**soniazid, **P**rocainamide (highest risk), **P**henytoin, **S**ulfonamides. * **Other notable triggers:** Minocycline, Quinidine, and Anti-TNF alpha agents (e.g., Etanercept). * **Clinical Distinction:** Unlike idiopathic SLE, DILE rarely involves the CNS or Kidneys and usually resolves upon discontinuation of the offending drug. * **Lab Marker:** Anti-Histone antibodies are the most specific screening test for DILE.
Explanation: **Explanation:** **Serotonin Syndrome** is a potentially life-threatening condition caused by excessive serotonergic activity in the central and peripheral nervous systems. It is typically precipitated by the administration of drugs that increase serotonin synthesis, release, or activation of receptors, or those that inhibit its reuptake or metabolism. **Why Chlorpromazine is the correct answer:** Chlorpromazine is a typical antipsychotic that primarily acts as a **D2 receptor antagonist**. Crucially, it also possesses **5-HT2A receptor antagonist** properties. Because it blocks serotonin receptors rather than stimulating them, it does not precipitate serotonin syndrome. In fact, serotonin antagonists (like Cyproheptadine or Chlorpromazine) are sometimes used off-label in the management of the syndrome to counteract the excess serotonergic activity. **Analysis of Incorrect Options:** * **Meperidine (Pethidine):** An opioid analgesic that acts as a weak Serotonin Reuptake Inhibitor (SRI). It is a classic trigger for serotonin syndrome, especially when combined with MAO inhibitors. * **Pentazocine:** An opioid with mixed agonist-antagonist properties that also inhibits serotonin reuptake, posing a risk for the syndrome. * **Buspirone:** An anxiolytic that acts as a **partial agonist at 5-HT1A receptors**. By directly stimulating serotonin receptors, it can contribute to the syndrome. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad:** Cognitive effects (delirium, agitation), Autonomic hyperactivity (hypertension, tachycardia, hyperthermia), and Neuromuscular abnormalities (clonus, hyperreflexia). * **Key Sign:** **Lower limb clonus** is the most characteristic physical finding. * **Common Culprits:** SSRIs, SNRIs, MAOIs, TCAs, Tramadol, Linezolid (weak MAOI), and St. John's Wort. * **Antidote:** **Cyproheptadine** (5-HT2 receptor antagonist) is the specific drug of choice for severe cases.
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free